Medgend Icon


Kazano FDA Approved Drugs

KAZANO [Alogliptin BenzoateC18H21N5O2C7H6O2 : Metformin HydrochlorideC4H11N5ClH]
RX
-
eq 12.5mg base : 1gm (oral tablet)
eq 12.5mg base : 500mg (oral tablet)
Takeda Pharms UsaJan 25, 2013
  • Method of treating diabetes comprising administering a compound such as alogliptin.
  • Method of treating diabetes comprising administering alogliptin.
  • Methods of lowering elevated post prandial blood glucose levels comprising administering a dipeptidyl peptidase inhibitor.
  • Methods of modifying glucose metabolism and treating diabetes comprising administering a dipeptidyl peptidase inhibitor and one or more other therapeutic agents such as metformin.
  • Methods of reducing the side effects of active components administered to a diabetic patient comprising administering an insulin sensitivity enhancer such as pioglitazone in combination with an insulin secretion enhancer.
  • Methods of treating diabetes comprising administering a dipeptidyl peptidase inhibitor and metformin.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.